Ireland authorized Aurora’s cannabidiol solution beneath its Healthcare Cannabis Access System (MCAP) for the remedy of spasticity connected to many sclerosis, chemotherapy-induced nausea and vomiting and remedy-resistant epilepsy. It is one particular of only two products to date to obtain such authorization beneath the plan.
Aurora’s Chief Solution Officer, Dr. Shane Morris, stated he expects the firm will be capable to provide treatment options for far more healthcare circumstances in the future.
“We appear forward to far more of Aurora’s higher-high quality medicines becoming authorized, so that far more individuals can advantage from the MCAP in Ireland,” he stated in a news release. “We will continue to function closely with all parties and state agencies to facilitate additional availability.”
Ireland’s Minister for Wellness, Simon Harris, signed MCAP into law in June. It aims to facilitate access to cannabis-primarily based healthcare goods and is scheduled to run for five years